Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
UI-059 by Korea United Pharm for Reflux Esophagitis (Gastroesophageal Reflux Disease): Likelihood of Approval
UI-059 is under clinical development by Korea United Pharm and currently in Phase I for Reflux Esophagitis (Gastroesophageal Reflux Disease)....